Showing results (361-370 of 389) with videos related to
Sort By:
Pageof 39
Blood|May 16, 1998
Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcomeG Nadali, L Tavecchia, E Zanolin, et al.Lancet (London, England)|March 3, 1984
Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipientsH G Prentice, H A Blacklock, G Janossy, et al.Immunology Letters|April 15, 1999
'Naïve' and 'memory' CD4+ T-cells and T-cell receptor (TCR) V beta repertoire dynamics are independent of the levels of viremia following HIV seroconversionD J King, P Amjadi, R Tilling, et al.Cellular Immunology|January 1, 1989
The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodiesJ L Li, G L Shen, M A Ghetie, et al.Blood|January 1, 1997
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytesR Zambello, M Facco, L Trentin, et al.Journal of Immunological Methods|November 1, 2001
Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settingsV Jani, G Janossy, A Iqbal, et al.The Journal of Experimental Medicine|December 1, 1994
CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infectionR Manetti, F Annunziato, R Biagiotti, et al.Journal of Clinical Immunology|July 1, 1982
T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host diseaseG Janossy, L Montano, W S Selby, et al.Journal of Leukocyte Biology|May 1, 1997
In vivo CD30 expression in human diseases with predominant activation of Th2-like T cellsM M D'Elios, P Romagnani, C Scaletti, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1997
CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patientsA Mocroft, M Bofill, M Lipman, et al.Pageof 39